| Dr Natalia Mendoza, MD | |
|
Route 301 North B Avenue, Zuni Comprehensive Community Health Center, Zuni, NM 87327 | |
| (505) 782-4431 | |
| (505) 782-7405 |
| Full Name | Dr Natalia Mendoza |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | Route 301 North B Avenue, Zuni, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528352200 | NPI | - | NPPES |
| 03671267 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 60393010 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Zuni Comprehensive Community Health Center | Zuni, NM | Hospital |
| Cibola General Hospital | Grants, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Zuni Indian Hospital | 5698689644 | 57 |
News Archive
Rice University and Canadian global health design firm Metric Technologies have developed an automated bag valve mask ventilation unit that can be built for less than $300 worth of parts and help patients in treatment for COVID-19.
An international team led by University of Adelaide researchers has identified the mechanism of pain relief of a new drug for treating Irritable Bowel Syndrome with Constipation (IBS-C), based on nonclinical studies, and quantified its effectiveness in pain relief in human trials.
Since the 1960s, it has been known that groundwater resources in certain provinces of China are contaminated with arsenic. Estimates of the numbers of affected people have risen year by year. In the most recent survey - conducted by the Chinese Ministry of Health between 2001 and 2005 - more than 20,000 (5%) of the 445,000 wells tested showed arsenic concentrations higher than 50 -g/L.
Brazil, China, India and South Africa, which together account for nearly half of all new tuberculosis (TB) cases, offer "tremendous opportunities" for new diagnostics due to their commitment to fight the disease at a time when investments in new technologies are on the increase, according to a new report from FIND, McGill International TB Centre, and UNITAID.
BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the U.S. Food and Drug Administration (FDA) has agreed that BioVex's ongoing OPTiM clinical study in unresectable Stage IIIb-IV melanoma be amended to include untreated (i.e., first line) patients as well as previously treated patients as defined in the original protocol.
› Verified 1 days ago
| Entity Name | Zuni Indian Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497843734 PECOS PAC ID: 5698689644 Enrollment ID: O20031114000284 |
News Archive
Rice University and Canadian global health design firm Metric Technologies have developed an automated bag valve mask ventilation unit that can be built for less than $300 worth of parts and help patients in treatment for COVID-19.
An international team led by University of Adelaide researchers has identified the mechanism of pain relief of a new drug for treating Irritable Bowel Syndrome with Constipation (IBS-C), based on nonclinical studies, and quantified its effectiveness in pain relief in human trials.
Since the 1960s, it has been known that groundwater resources in certain provinces of China are contaminated with arsenic. Estimates of the numbers of affected people have risen year by year. In the most recent survey - conducted by the Chinese Ministry of Health between 2001 and 2005 - more than 20,000 (5%) of the 445,000 wells tested showed arsenic concentrations higher than 50 -g/L.
Brazil, China, India and South Africa, which together account for nearly half of all new tuberculosis (TB) cases, offer "tremendous opportunities" for new diagnostics due to their commitment to fight the disease at a time when investments in new technologies are on the increase, according to a new report from FIND, McGill International TB Centre, and UNITAID.
BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the U.S. Food and Drug Administration (FDA) has agreed that BioVex's ongoing OPTiM clinical study in unresectable Stage IIIb-IV melanoma be amended to include untreated (i.e., first line) patients as well as previously treated patients as defined in the original protocol.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Natalia Mendoza, MD Po Box 467, Zuni Comprehensive Community Health Center Med Staff, Zuni, NM 87327-0467 Ph: (505) 782-4431 | Dr Natalia Mendoza, MD Route 301 North B Avenue, Zuni Comprehensive Community Health Center, Zuni, NM 87327 Ph: (505) 782-4431 |
News Archive
Rice University and Canadian global health design firm Metric Technologies have developed an automated bag valve mask ventilation unit that can be built for less than $300 worth of parts and help patients in treatment for COVID-19.
An international team led by University of Adelaide researchers has identified the mechanism of pain relief of a new drug for treating Irritable Bowel Syndrome with Constipation (IBS-C), based on nonclinical studies, and quantified its effectiveness in pain relief in human trials.
Since the 1960s, it has been known that groundwater resources in certain provinces of China are contaminated with arsenic. Estimates of the numbers of affected people have risen year by year. In the most recent survey - conducted by the Chinese Ministry of Health between 2001 and 2005 - more than 20,000 (5%) of the 445,000 wells tested showed arsenic concentrations higher than 50 -g/L.
Brazil, China, India and South Africa, which together account for nearly half of all new tuberculosis (TB) cases, offer "tremendous opportunities" for new diagnostics due to their commitment to fight the disease at a time when investments in new technologies are on the increase, according to a new report from FIND, McGill International TB Centre, and UNITAID.
BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the U.S. Food and Drug Administration (FDA) has agreed that BioVex's ongoing OPTiM clinical study in unresectable Stage IIIb-IV melanoma be amended to include untreated (i.e., first line) patients as well as previously treated patients as defined in the original protocol.
› Verified 1 days ago
Angelina Shigeura, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Route 301 North B Street, Zuni, NM 87327 Phone: 505-782-7450 | |
Rebecca H Ryan, MD Family Medicine Medicare: Medicare Enrolled Practice Location: Route 301 N 21 B Ave, Zuni, NM 87327 Phone: 505-782-4431 Fax: 505-782-4502 | |
Dr. Nadra Crawford, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Route 301 North, Zuni, NM 87327 Phone: 505-782-4431 Fax: 505-782-4502 | |
Karthik Kavasseri, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Route 301 North, Zuni, NM 87327 Phone: 505-782-4431 Fax: 505-782-4502 | |
Dr. Emma Oberlander, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Route 301 North, Zuni, NM 87327 Phone: 505-782-4431 Fax: 505-782-4502 | |
Ashwini Mathai, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: Route 301 N 21 B Avenue, Zuni, NM 87327 Phone: 505-782-4431 | |
Kristen Lenore Zozulin, MD Family Medicine Medicare: Medicare Enrolled Practice Location: Rte 301 N 21b Ave, Zuni, NM 87327 Phone: 505-782-7456 |